Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2024

Venkadakrishnan VB, Presser AG, Singh R, Booker MA, Traphagen NA, Weng K, et al. Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes. Res Sq. 2024.

Daman AW, Antonelli AC, Redelman-Sidi G, Paddock L, Cheong JG, Jurado LF, et al. Microbial cancer immunotherapy reprograms hematopoietic stem cells to enhance anti-tumor immunity. bioRxiv. 2024.

Conway J, Magro CM, Lipner SR. Expanding the Differential Diagnosis of the Painful Nail: A Case of an Onychopapilloma with Neuroma. Case Rep Dermatol. 2024;16(1):88-93.

Galbraith K, Serrano J, Shen G, Tran I, Slocum CC, Ketchum C, et al. Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors. Mol Cancer Res. 2024;22(1):21-28.

Soderquist CR, Freeman C, Lin W-, Leeman-Neill RJ, Gu Y, Carter MC, et al. Clinical Utility and Reimbursement of Next-Generation Sequencing-Based Testing for Myeloid Malignancies. J Mol Diagn. 2024;26(1):5-16.

Ohara K, Rendeiro AF, Bhinder B, Eng KW, Ravichandran H, Nguyen D, et al. The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis. Nat Commun. 2024;15(1):2009.

Centeno BA, Saieg M, Siddiqui MT, Perez-Machado M, Layfield LJ, Weynand B, et al. The World Health Organization Reporting System for Pancreaticobiliary Cytopathology: Overview and Summary. Cancer Cytopathol. 2024;132(7):396-418.

Deng Q, Lakra P, Gou P, Yang H, Meydan C, Teater M, et al. SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions. Cancer Cell. 2024.

Manning JC, Boza JM, Cesarman E, Erickson D. Rapid, equipment-free extraction of DNA from skin biopsies for point-of-care diagnostics. Sci Rep. 2024;14(1):13782.

Gokozan HN, Scognamiglio T. Solitary fibrous tumor of deep parotid gland preoperatively classified as salivary gland neoplasm of uncertain malignant potential by the Milan system for reporting salivary gland cytopathology: A common diagnosis for a rare entity. Diagn Cytopathol. 2024.